Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Appointed director
Quarterly results
CC transcript
|
|
HUMAN GENOME SCIENCES INC (HGSI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2013 |
SC 13G/A
| TCW GROUP INC reports a 0% stake in Human Genome Sciences, Inc. |
| 02/13/2013 |
SC 13G/A
| Capital Research Global Investors reports a 0% stake in Human Genome Sciences, Inc |
| 09/10/2012 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/17/2012 |
4/A
| Watkins Thomas (CEO) has filed a Form 4 on HUMAN GENOME SCIENCES INC|
Txns:
| Gifted 2,000 shares
@ $0
Bought 1,030 shares
@ $20.62, valued at
$21.2k
Gifted 5,000 shares
@ $0
Bought 3,364 shares
@ $6.32, valued at
$21.3k
Gifted 167,000 shares
@ $0
Unknown transaction of 10,469 shares
@ $14.25, valued at
$149.2k
|
|
| 08/13/2012 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 08/13/2012 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 08/09/2012 |
CT ORDER
| Form CT ORDER - Confidential treatment order |
| 08/09/2012 |
3
| Connelly Deirdre P (President & CEO) has filed a Form 3 on HUMAN GENOME SCIENCES INC |
| 08/09/2012 |
3
| Connor Roger (Director) has filed a Form 3 on HUMAN GENOME SCIENCES INC |
| 08/09/2012 |
3
| Koczynski Chester (Director) has filed a Form 3 on HUMAN GENOME SCIENCES INC |
| 08/09/2012 |
3
| Rawcliffe Adrian (Chief Financial Officer) has filed a Form 3 on HUMAN GENOME SCIENCES INC |
| 08/09/2012 |
3
| Redfern David (Director) has filed a Form 3 on HUMAN GENOME SCIENCES INC |
| 08/09/2012 |
3
| Tomlinson Ian (Director) has filed a Form 3 on HUMAN GENOME SCIENCES INC |
| 08/09/2012 |
3
| Troy Daniel (Secretary) has filed a Form 3 on HUMAN GENOME SCIENCES INC |
| 08/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/09/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 08/09/2012 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 08/08/2012 |
8-K
| Quarterly results |
| 08/03/2012 |
4
| GLAXOSMITHKLINE PLC (10% Owner) has filed a Form 4 on HUMAN GENOME SCIENCES INC|
Txns:
| Bought 5,686,715 shares
@ $14.25, valued at
$81M
Bought 3,413,699 shares
@ $14.25, valued at
$48.6M
Bought 59,232,487 shares
@ $14.25, valued at
$844.1M
|
|
| 08/03/2012 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 08/03/2012 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 08/01/2012 |
4
| GLAXOSMITHKLINE PLC (10% Owner) has filed a Form 4 on HUMAN GENOME SCIENCES INC|
Txns:
| Bought 4,934,743 shares
@ $14.25, valued at
$70.3M
Bought 1,788,186 shares
@ $14.25, valued at
$25.5M
|
|
| 08/01/2012 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 08/01/2012 |
8-K
| Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an... |
| 08/01/2012 |
4
| Watkins Thomas (CEO) has filed a Form 4 on HUMAN GENOME SCIENCES INC|
Txns:
| Gifted 166,075 shares
@ $14.25, valued at
$2.4M
Disposed/sold 400,000 options to buy
@ $10.62, valued at
$4.2M
Disposed/sold 500,000 options to buy
@ $4.92, valued at
$2.5M
Disposed/sold 500,000 options to buy
@ $0.52, valued at
$260k
Disposed/sold 360,000 options to buy
@ $8.23, valued at
$3M
Disposed/sold 325,000 options to buy
@ $10.89, valued at
$3.5M
Disposed/sold 1,250,000 options to buy
@ $10.47, valued at
$13.1M
|
|
| 08/01/2012 |
4/A
| Simpson Curran (Sr. VP, Operations) has filed a Form 4 on HUMAN GENOME SCIENCES INC|
Txns:
| Disposed/sold 8,334 shares
@ $14.25, valued at
$118.8k
Disposed/sold 18,000 shares
@ $14.25, valued at
$256.5k
|
|
| 08/01/2012 |
4
| YOUNG ROBERT C (Director) has filed a Form 4 on HUMAN GENOME SCIENCES INC|
Txns:
| Disposed/sold 4,166 shares
@ $14.25, valued at
$59.4k
Unknown transaction of 13,834 shares
@ $14.25, valued at
$197.1k
Disposed/sold 18,852 shares
@ $14.25, valued at
$268.6k
Disposed/sold 16,000 options to buy
@ $11.33, valued at
$181.3k
Disposed/sold 16,000 options to buy
@ $10.7, valued at
$171.2k
Disposed/sold 13,170 options to buy
@ $2.09, valued at
$27.5k
Disposed/sold 16,000 options to buy
@ $5.97, valued at
$95.5k
Disposed/sold 16,000 options to buy
@ $14.23, valued at
$227.7k
Disposed/sold 22,000 options to buy
@ $8.68, valued at
$191k
|
|
| 08/01/2012 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on HUMAN GENOME SCIENCES INC|
Txns:
| Disposed/sold 4,166 shares
@ $14.25, valued at
$59.4k
Unknown transaction of 17,776 shares
@ $14.25, valued at
$253.3k
Disposed/sold 16,000 options to buy
@ $11.33, valued at
$181.3k
Disposed/sold 16,000 options to buy
@ $10.7, valued at
$171.2k
Disposed/sold 16,000 options to buy
@ $2.09, valued at
$33.4k
Disposed/sold 16,000 options to buy
@ $5.97, valued at
$95.5k
Disposed/sold 16,000 options to buy
@ $14.23, valued at
$227.7k
Disposed/sold 48,000 options to buy
@ $10.69, valued at
$513.1k
Disposed/sold 16,000 options to buy
@ $11.51, valued at
$184.2k
|
|
|
|
|